These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 1855324

  • 41. Results of a controlled drug trial in membranoproliferative glomerulonephritis.
    Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN.
    Kidney Int; 1985 Feb; 27(2):436-41. PubMed ID: 3886998
    [Abstract] [Full Text] [Related]

  • 42. ANCA-associated crescentic IgA glomerulonephritis in pregnancy.
    Amir AR, Sheikh SS.
    J Nephrol; 2002 Feb; 15(6):716-9. PubMed ID: 12495291
    [Abstract] [Full Text] [Related]

  • 43. Wegener's granulomatosis with rapidly progressive glomerulonephritis.
    Kaushal R, Dash SC, Kapur S, Bhuyan UN.
    J Assoc Physicians India; 1987 May; 35(5):382-4. PubMed ID: 3693295
    [No Abstract] [Full Text] [Related]

  • 44. Assessment of the interaction of warfarin with aspirin and dipyridamole.
    Donaldson DR, Sreeharan N, Crow MJ, Rajah SM.
    Thromb Haemost; 1982 Feb 26; 47(1):77. PubMed ID: 6978549
    [No Abstract] [Full Text] [Related]

  • 45. Does growth hormone therapy induce IgA nephropathy?
    Kano K, Nishikura K, Arisaka O.
    Pediatr Nephrol; 2005 Dec 26; 20(12):1821-2. PubMed ID: 16222552
    [No Abstract] [Full Text] [Related]

  • 46. IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome.
    Richer C, Mouthon L, Cohen P, Buchet P, Royer I, Guettier C, Guillevin L.
    Clin Nephrol; 1999 Jul 26; 52(1):47-50. PubMed ID: 10442496
    [Abstract] [Full Text] [Related]

  • 47. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM, Cabezas A, Calero F, Ballarín JA.
    Nefrologia; 2004 Jul 26; 24 Suppl 3():68-71. PubMed ID: 15219073
    [Abstract] [Full Text] [Related]

  • 48. Effect of PA-MSHA vaccine on plasma phospholipids metabolic profiling and the ratio of Th2/Th1 cells within immune organ of mouse IgA nephropathy.
    Jia L, Wang C, Kong H, Yang J, Li F, Lv S, Xu G.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):646-54. PubMed ID: 16935452
    [Abstract] [Full Text] [Related]

  • 49. [Concomitant therapy with prednisolone and cyclophosphamide in 18 cases of IgA nephropathy].
    Kawaguchi S, Matsuzaki T, Sato R, Katsumata Y.
    Nihon Naika Gakkai Zasshi; 1986 May 17; 75(5):611-7. PubMed ID: 3746074
    [No Abstract] [Full Text] [Related]

  • 50. [Treatment of childhood IgA nephropathy].
    Yoshikawa N.
    Nihon Jinzo Gakkai Shi; 2008 May 17; 50(4):468-72. PubMed ID: 18546876
    [No Abstract] [Full Text] [Related]

  • 51. Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
    Kalowski S, Kincaid-Smith P.
    Med J Aust; 1973 Jul 28; 2(4):164-6. PubMed ID: 4741342
    [No Abstract] [Full Text] [Related]

  • 52. The effects of anti-thrombotic therapy in renal disease.
    Kincaid-Smith P.
    Scand J Haematol Suppl; 1979 Jul 28; 34():83-9. PubMed ID: 384508
    [No Abstract] [Full Text] [Related]

  • 53. Myocardial ischemia during methylprednisolone pulse therapy with dipyridamole.
    Tsukahara T, Matsuoka D, Shimada S, Hachiya A, Motoki N.
    Pediatr Int; 2021 Jun 28; 63(6):722-723. PubMed ID: 33848036
    [No Abstract] [Full Text] [Related]

  • 54. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U.
    Am J Med; 1983 Dec 28; 75(6):920-7. PubMed ID: 6359877
    [Abstract] [Full Text] [Related]

  • 55. Effects of dipyridamole on the short-term evolution of glomerulonephritis.
    Camara S, de la Cruz JP, Frutos MA, Sanchez P, Lopez de Novales E, Sanchez E, Sanchez de la Cuesta F.
    Nephron; 1991 Dec 28; 58(1):13-6. PubMed ID: 1857478
    [Abstract] [Full Text] [Related]

  • 56. Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
    Donadio JV, Offord KP.
    Am J Kidney Dis; 1989 Dec 28; 14(6):445-51. PubMed ID: 2596471
    [Abstract] [Full Text] [Related]

  • 57. [Onset, mechanism of development, and therapy of IgA nephropathy].
    Tomino Y.
    Nihon Naika Gakkai Zasshi; 2000 Nov 10; 89(11):2365-70. PubMed ID: 11142825
    [No Abstract] [Full Text] [Related]

  • 58. Management in immunoglobulin A nephropathy.
    Kittisupamongkol W.
    Hong Kong Med J; 2009 Apr 10; 15(2):158. PubMed ID: 19342748
    [No Abstract] [Full Text] [Related]

  • 59. Mendelian Randomization Unveils Drug Targets for IgA Nephropathy.
    Khan A, Lim TY, Sanna-Cherchi S.
    J Am Soc Nephrol; 2024 Aug 01; 35(8):988-991. PubMed ID: 38995687
    [No Abstract] [Full Text] [Related]

  • 60. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R, Wu W, Wen Y, Li X.
    Int Urol Nephrol; 2017 Jul 01; 49(7):1233-1241. PubMed ID: 28349446
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.